We read with interest the article entitled "Is ln-Stent Restenosis After a Successful Coronary Stent Implantation Due to Stable Angina Associated With TG/HDL-C Ratio?" by Kundi et al. 1 They reported a significant association between triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) ratio and in-stent restenosis (ISR). 1 Despite major advances in interventional techniques and drug therapy, ISR remains a major problem in interventional cardiology. Several inflammatory biomarkers have been investigated in the setting of coronary stenting to stratify the risk of both angiographic and clinical outcomes. 2, 3 Inflammation and oxidative stress are involved in atherosclerosis and are thought to contribute to the initiation and progression of ISR. 3, 4 Many inflammatory and oxidative biomarkers including C-reactive protein (CRP), monocyte-to-HDL-C cholesterol ratio (MHR), and resting heart rate have been demonstrated to be independent risk factors for atherosclerosis, ISR, and cardiovascular events. [3] [4] [5] [6] In the study by Kundi et al, it was clear that the white blood cell count was higher, whereas neutrophil and lymphocyte count were lower in the ISR (þ) group when compared to the ISR (À) group ( Table 2) . 1 Then, we could estimate that the monocyte count is higher in the ISR (þ) group. In addition, the MHR was also more likely higher in the ISR (þ) group since HDL-C was lower in the ISR (þ) group. However, the authors did not report these parameters. 1 It would be useful if the authors provided CRP, MHR, and resting heart rate values of their study population. 1 Besides, they did not include these possible confounding factors in Cox regression analysis. Another question about the study 1 is that, as the authors mentioned as limitations, TG levels of some patients were calculated from nonfasting blood samples. It is possible that this rate was higher in the ISR (þ) group. Hence, the study findings as regard independent predictors of ISR may be misleading.
